AbbVie inks $10.9B Apogee buyout to bag hotly tipped eczema prospect
Source: news.google.com
Published: Jun 22, 2026 11:59
Source: news.google.com
Published: Jun 22, 2026 11:59
Related Stories
‘Too Good to Be True:’ A Chinese Study on Timing Cancer Therapy Is Retracted The New York Times
#Clinical TrialsNew oral heart failure drug appears to be safe and well tolerated in 58-patient early clinical trial Medical Xpress
#Clinical TrialsClinical study of drug-resistant tuberculosis changes global medical practice Medical Xpress
#Clinical TrialsMerck KGaA to acquire Bio-Techne for $11.3B cash The Pharmaletter
#Biotech HeadlinesBiotech ETF Index Surges 10% After Rebalance ETF Database
#Biotech HeadlinesThe China debate gets louder in Washington statnews.com
#Biotech HeadlinesAdd Shortcut
Open this site faster like an app from your phone home screen.